Iron Deficiency and the Risk of Incident Left Ventricular Dysfunction in Patients with Coronary Artery Disease: A Single-center Cohort Study
Background: Heart failure (HF) is a complex and life-threatening condition that often coexists with comorbidities such as hypertension, type 2 diabetes mellitus, coronary artery disease (CAD), and iron deficiency (ID). However, the relationship between ID and the development of HF remains poorly und...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/jmedsci.jmedsci_12_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
Heart failure (HF) is a complex and life-threatening condition that often coexists with comorbidities such as hypertension, type 2 diabetes mellitus, coronary artery disease (CAD), and iron deficiency (ID). However, the relationship between ID and the development of HF remains poorly understood.
Aim:
This study aimed to investigate the correlation between ID and the development of left ventricular dysfunction.
Methods:
A total of 64,661 patients diagnosed with CAD at a tertiary hospital between 2011 and 2023 were recruited. Of these, 4813 patients who underwent iron status evaluation, including serum iron (SI), total iron-binding capacity (TIBC), and ferritin within 30 days, were included in the analysis. We compared the incidence and hazard ratio (HR) of new-onset left ventricular (LV) dysfunction (LV ejection fraction <50%) between patients with and without ID, defined as SI/TIBC or transferrin saturation (TSAT) <20% or ferritin <100 ng/mL.
Results:
The incidence of new-onset LV dysfunction was higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT (HR, 1.40; 95% confidence interval [CI], 1.14–1.72) over a 13-year follow-up. In multivariable analysis, TSAT <20% retained its predictive value for new-onset LV dysfunction (adjusted HR, 1.24; 95% CI, 1.01–1.54), while ferritin levels were not correlated with the incidence of new-onset LV dysfunction in this cohort. The all-cause mortality rate was also higher in patients with ID, defined by TSAT <20% compared to those with normal TSAT. A subgroup analysis revealed no significant difference in predicting new-onset LV dysfunction between patients with ID, with or without coexisting anemia (P = 0.165).
Conclusion:
In patients with CAD, ID, particularly defined by TSAT <20%, was predictive of future LV dysfunction and associated outcomes. Further studies are needed to investigate the underlying mechanisms and causal relationship between ID and the risk of LV dysfunction. |
|---|---|
| ISSN: | 1011-4564 2542-4939 |